<code id='1A42AB76FB'></code><style id='1A42AB76FB'></style>
    • <acronym id='1A42AB76FB'></acronym>
      <center id='1A42AB76FB'><center id='1A42AB76FB'><tfoot id='1A42AB76FB'></tfoot></center><abbr id='1A42AB76FB'><dir id='1A42AB76FB'><tfoot id='1A42AB76FB'></tfoot><noframes id='1A42AB76FB'>

    • <optgroup id='1A42AB76FB'><strike id='1A42AB76FB'><sup id='1A42AB76FB'></sup></strike><code id='1A42AB76FB'></code></optgroup>
        1. <b id='1A42AB76FB'><label id='1A42AB76FB'><select id='1A42AB76FB'><dt id='1A42AB76FB'><span id='1A42AB76FB'></span></dt></select></label></b><u id='1A42AB76FB'></u>
          <i id='1A42AB76FB'><strike id='1A42AB76FB'><tt id='1A42AB76FB'><pre id='1A42AB76FB'></pre></tt></strike></i>

          hotspot

          hotspot

          author:comprehensive    Page View:6477
          STAT's Damian Garde speaks with Mikael Dolsten and Mathai Mammen, in New York on March 21, 2024
          From left to right, STAT's Damian Garde; Mikael Dolsten, chief scientific officer of Pfizer research and development; and Rose Loughlin, Moderna’s senior vice president of early research and development, discuss the future of pharma at the STAT 2024 Breakthrough Summit East. STAT

          Drug development is more of a sprint than a marathon these days, thanks to more and better ways to target underlying biology and a more nuanced interpretation of precision medicine, three biotech leaders said at the STAT Breakthrough Summit East in New York Thursday.

          “We used to say, well, you may spend five years in the research phase, another five in development. Now I see a project that takes one year of research, from an idea to studies,” said Mikael Dolsten, chief scientific officer and president of Pfizer research and development. “Time is life. You care about patients. And when the distance to run is long, it holds back the energy and the inspiration.”

          advertisement

          Key to that success are transformative new technologies like messenger RNA, which powered vaccines developed by Pfizer with its partner BioNTech.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Medicare details structure of new drug price negotiation program
          Medicare details structure of new drug price negotiation program

          MedicareonFridayreleasednewdetailsabouthowitsnewdrugpricenegotiationprogramwillwork,justtwomonthsbef

          read more
          Explaining an after
          Explaining an after

          AdobeThisarticlewasadaptedfromSTAT’slatestreport,“Subgroupanalysis:howtoevaluateposthoctestsforsigni

          read more
          Cancer drug shortages should be causing more outrage
          Cancer drug shortages should be causing more outrage

          DrugshortagesareagrowingproblemintheU.S.,andashortageoflivesavingcancerdrugsinparticularhasreachedcr

          read more

          Lung cancer screening guidelines updated for cigarette smokers

          PASCALPOCHARD-CASABIANCA/AFPviaGettyImagesMostlungcancerscreeningguidelineshingeonhowmuchpeoplesmoke